Dual inhibitors of pde 7 and pde 4

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/52 (2006.01) A61K 31/00 (2006.01) A61K 31/505 (2006.01) C07D 403/12 (2006.01) C07D 417/12 (2006.01) C07D 417/14 (2006.01) C07D 471/04 (2006.01) C07D 473/00 (2006.01) C07D 473/16 (2006.01) C07D 487/04 (2006.01) C07D 491/10 (2006.01) C07D 498/10 (2006.01)

Patent

CA 2444436

Dual inhibitors of PDE7 and PDE4, together with their use to treat leukocyte activation-associated disorders (including transplant rejection, rheumatoid arthritis, inflammatory bowel disease, psoriasis, asthma, chronic obstructive pulmonary disease, lupus and multiple sclerosis), are provided herein.

L'invention concerne des doubles inhibiteurs de la PDE7 et de la PDE4, ainsi que leur utilisation pour traiter les troubles associés à l'activation leucocytaire (tels que rejets de transplants, polyarthrite rhumatoïde, maladie intestinale inflammatoire, psoriasis, asthme, bronchopneumopathie chronique obstructive, lupus et sclérose en plaques).

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Dual inhibitors of pde 7 and pde 4 does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Dual inhibitors of pde 7 and pde 4, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dual inhibitors of pde 7 and pde 4 will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1991094

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.